The NHS keeps reacting. Prevention starts with the hormone.
Nathan Chadwick · · 10 min read
Listen
TLDRRead the short version
- The NHS is outstanding at today's emergency and late to the years before it. Darzi found the money drifting into hospitals while governments promised the opposite.
- A short appointment ends in a tablet because a tablet can start today. In 2024/25 England dispensed 92.6 million antidepressant items. They are not all for depression, and they are not the enemy.
- Thyroid replacement is ordinary NHS care. Menopause guidance already says offer HRT, and do not reach for an antidepressant first for flushes. HRT prescribing more than quadrupled once that was taken seriously, and it still reaches affluent areas far more than deprived ones.
- The Diabetes Prevention Programme is prevention that already happened: measure insulin risk early, and change the trajectory before the diagnosis.
- Treat the hormone means the right blood test, or the clinical diagnosis the guideline already allows without one, then a treatment that matches, then a review. It does not mean stopping a medicine that is keeping you well.
After the crash#
The NHS is extraordinary at the thing that happens today. The heart attack. The broken hip. The child who cannot breathe. The person who is not safe to be left alone tonight. That part of the service is worth keeping, and worth funding properly.
It is much worse at the ten years before any of that.
Lord Darzi's investigation said this in public in 2024. Between 2006 and 2022 the share of the NHS budget spent on hospitals went from 47% to 58%. Governments had spent at least that long promising the reverse. Between 2009 and 2023 the number of nurses working in the community fell by 5%. Turn up at a typical A&E on a typical evening and the queue in front of you went from just under 40 people in 2009 to more than 100 in 2024. The system produces what it is built to produce. A crisis, a hospital, a reaction.
In July 2025 the government wrote the correction down. The 10 Year Health Plan has three shifts, and one of them is from sickness to prevention. A plan is a sentence. The prescription is the behaviour. A year and a bit later, the test is still the appointment.
None of what follows is medical advice. I am not a doctor. I am someone who spent a long time on the reactive side of this, and then read the papers.
The tablet is what today can do#
Someone sits down exhausted, flat, heavier than last year, sleeping badly, with no interest in anything, including the person they live with. For a long time the appointment around that person was built for about ten minutes. A study of English practices put the average face-to-face GP consultation at 9.2 minutes. The BMA and the Royal College of GPs have both argued for fifteen as the standard, and a lot of contacts now run longer because the patients got more complicated. The slot the service was designed around did not.
In a short window the honest options are thin. Listen. Name the distress. Start the one treatment that can begin before they leave the building. For mood, that treatment is usually an antidepressant.
In 2024/25 England dispensed 92.6 million antidepressant items, to an estimated 8.89 million people. Items have risen every year since 2015/16, from 61.9 million then. Those items are not all for depression. The same drugs are used for pain, migraine and other things, and the NHS Business Services Authority does not record why a prescription was written. Even with that caveat, this is a service that has made the tablet the default reply to feeling awful. Prescribing is also higher where life is harder: 42.8% more patients in the most deprived areas than the least.
That is not laziness. A GP with a full list, a therapy wait measured in months, and someone who is clearly struggling will start the thing they can start. I have said this before and I still mean it. The failure is what happens next, which is often nothing. The first prescription quietly becomes the diagnosis. Nobody goes back to ask why this body, this year.
I wrote about the personal version of that, twenty years of a mood label and a hormone result nobody requested, in the piece on SSRIs and low testosterone. This one is the pattern.
The hormone was often the earlier fact#
A symptom is a description. Flat mood, fatigue, weight that will not move, brain fog, lost libido, wrecked sleep, periods that have changed. Each of those can be a life, a grief, a job, a thyroid, an ovary, a testis, an insulin signal, or several at once. Depression is a description. So is "getting older". Neither is an explanation.
The NHS already runs this properly for one hormone, and nobody calls it alternative medicine. If your thyroid has failed, you are prescribed levothyroxine, the blood is repeated, and the dose is changed until the number and the person agree. The treatment is a tablet. The tablet is the hormone, replaced, and then checked. That is the whole model.
Menopause is where the service spent years doing it backwards, and then, unevenly, started doing it the right way.
NICE NG23 is plain. Offer HRT for menopausal hot flushes and night sweats. Do not routinely offer an SSRI or an SNRI as the first treatment for those symptoms on their own. If low mood starts with the rest of the menopause and it does not meet the criteria for a depressive illness, consider HRT for the mood as well. If HRT has not fixed low sexual desire, consider testosterone. Versions of this have been in the guideline for a decade. Women were still handed an antidepressant for a hormone change, because low mood is a label the appointment already knows how to code.
There is a detail the blood-test crowd usually get wrong, and it matters. For an otherwise healthy person of 45 or over, NICE says identify perimenopause and menopause from the symptoms and the cycle, without laboratory tests. It specifically says do not use an oestradiol level to make that diagnosis. FSH is for a narrower job, roughly ages 40 to 45, and under 40 when premature ovarian insufficiency is the question. Waiting for a blood test to "permit" menopause care at 50 is not thorough. It is a delay the guideline already refused.
Then the prescribing moved, which is the proof the culture can change. HRT items in England went from 3.1 million in 2015/16 to 13.3 million in 2023/24. The number of people receiving them went from about 1.0 million to 2.6 million. No new molecule did that. Patients, campaigners and a slice of general practice refused the shortcut, and the system followed. Oestrogen was on the shelf the whole time.
Look at who received it. In 2023/24 about 740,000 people in the least deprived areas of England were prescribed HRT, and about 325,000 in the most deprived. More than double. Antidepressant prescribing runs the other way. I am not claiming every antidepressant in a deprived postcode was a missed menopause. I am claiming the familiar tablet and the hormone treatment are not landing on the same people.
Prevention the service has already proved#
Prevention is not a poster, and it is not "have you tried being less stressed" instead of medicine.
The NHS Diabetes Prevention Programme takes people whose HbA1c is already in the prediabetic range and tries to stop the next diagnosis. In the early cohorts, people who completed it lost on average 3.3 kg, and their HbA1c fell by about 2 mmol/mol. A Nature study of ordinary English primary care, using a design that can support a causal claim, found that being referred improved HbA1c, weight and lipids. A Lancet Regional Health paper found type 2 diabetes incidence in the first wave of practices running about 6% lower than expected.
That is the preventive move. Measure a trajectory while it is still a trajectory. Intervene before the label hardens into a disease and a lifetime of tablets that chase the damage.
Insulin is a hormone. Metformin, and the weight-loss medicines the 10 Year Plan said the NHS would roll out, are what you reach for once the trajectory has arrived. Some of those drugs are genuinely good. They are still the reaction. The blood test a few years earlier was the prevention.
Where the looking still stops#
Thyroid has a pathway. Menopause has a guideline, followed unevenly and followed less where people have less money. Male testosterone barely has a front door.
There is no NICE guideline for testosterone deficiency in men. A Delphi consensus across the NHS describes a service where GPs largely do not manage it, in part because they are not confident to. The specialist thresholds, and the trap of a result that is "normal" for a population while the man in front of you is not, are in the other post. I will not replay my own numbers. The short version is that the appointment often has nothing it is trained or supported to do next except the antidepressant, something for sleep, or advice to lose weight and come back. Weight, alcohol, broken sleep and depression itself all suppress the axis. That is a reason to measure properly, in the morning, fasted, and to repeat it. It is not a reason to skip the blood and guess.
Women get a version of the same shrug outside the window everyone recognises. Perimenopause can start in the late thirties. Cycles change, anxiety arrives out of a clear sky, sleep dies, and the notes say generalised anxiety because nobody asked when the periods changed. From 45, NICE already says you do not need a lab to think of it. Thinking of it is free. It loses to the label that already has a prescription attached.
Polycystic ovary syndrome is the other pattern I keep seeing described. A contraceptive pill can be the right prescription, for bleeding and for contraception. It can also be the entire plan. For a lot of women the driver underneath is insulin resistance, and a pill that regulates a bleed does not treat that driver. A sentence of lifestyle advice across a short appointment does not either. Measure the metabolic side, and treat what you find, or the same person comes back later with prediabetes and a mood record.
This is not "everything is hormones". Infection is infection. Cancer is cancer. A bereavement is a bereavement. Trauma is not a low oestradiol result. "Adrenal fatigue" is not a diagnosis, however tired you are. A person in a mental health crisis needs the crisis service, not a stranger on the internet talking about bloods. If an antidepressant is the thing keeping you here, it is doing a job. Coming off it belongs in a conversation with the prescriber, usually over months, not in a decision you make because a blog post annoyed you. NICE rewrote its depression guidance to say withdrawal can be severe and prolonged. Do not stop suddenly.
What treating the hormone means#
It does not mean a clinic selling a long panel and a monthly protocol. It does not mean buying a hormone off the internet because the NHS shrugged. Getting this wrong has harms: too much thyroid hormone, HRT in the wrong person or the wrong formulation, testosterone shutting down sperm production, a number treated because it was a number.
It means the order changes.
When the story is fatigue, mood, weight, libido, cycles or sleep, ask the question that fits the story. Thyroid, full blood count, ferritin, B12, folate, vitamin D, HbA1c, and the sex hormones that are actually informative for the person in front of you. For men with those symptoms, that includes testosterone, done properly, more than once. For menopause at the usual age, the informative step is often the history, not another vial, and then a decision about HRT. Say the number out loud when a number was taken. "Normal" is a lab's description of a population.
Then treat the thing you found. Sometimes the treatment is a hormone, as a tablet, a gel or a patch, reviewed against a repeat blood test and against how the person actually feels. Sometimes it is sleep, alcohol, food, training, a diabetes prevention place, or leaving a life that is grinding the axis into the floor. Sometimes it is still an antidepressant, chosen on purpose, after the other questions, with a date in the diary to ask whether it worked.
Darzi's point was that the money and the targets sit in the hospital, so the hospital is what grows. A preventive NHS would put the same seriousness into the contact that happens before anyone is ill enough to be counted. Long enough when the problem is a system and not a sore throat. The same clinician often enough that a result has somewhere to land. Hormone treatment available because it is indicated, on the same terms in a deprived town as in an affluent one, and not withheld because the more familiar drug is faster to start.
The 10 Year Plan already promised the shift from sickness to prevention. Holding the service to that does not need a new slogan. It needs the hormone question before the repeat prescription, and a willingness to treat the hormone when the answer is yes.
If you are the person in the appointment: ask what was actually considered, and what the number was if a number exists. Ask whether this could be thyroid, menopause, testosterone, insulin, iron or sleep, before the next drug is stacked on the last one. If tonight is the crisis, that question waits until morning. Samaritans are on 116 123, free, at any time. NHS 111, and the mental health option. If you are in danger, 999.
References#
- Darzi, Independent investigation of the NHS in England, summary letter (2024)
- Fit for the future: 10 Year Health Plan for England, executive summary
- Stevens and others, consultation duration in English general practice (BMJ Open, 2017)
- BMA, safe working in general practice: appointments
- RCGP, on consultation length
- NHSBSA, medicines used in mental health, England, 2015/16 to 2024/25
- NHSBSA, antidepressant summary tables, including deprivation
- NICE NG23, menopause: identification and management
- NHSBSA, hormone replacement therapy, England, April 2015 to June 2024
- Valabhji and others, early outcomes from the NHS Diabetes Prevention Programme (Diabetes Care, 2020)
- Lemp and others, evaluation of the NHS Diabetes Prevention Programme (Nature, 2023)
- McManus and others, population impact of the NHS DPP on type 2 diabetes incidence (Lancet Regional Health – Europe, 2022)
- Male testosterone deficiency across the NHS: a Delphi consensus
- NICE NG222, depression in adults
- Samaritans